文献速递乳房整形与再造

脱细胞真皮基质是否增加即刻扩张器-假体乳房再造一期重建术后并发症:匹配队列研究

Does the Use of Acellular Dermal Matrix Increase Postoperative Complications of the First-Stage Reconstruction of Immediate Expander-Implant Breast Reconstruction: A Matched Cohort Study.
PubMed 文献 · Ann Plast Surg · 2017-01-01

该回顾性匹配队列研究纳入2010年2月至2016年1月间574例即刻扩张器-假体乳房再造(533例患者),经倾向性评分匹配后比较398例重建(ADM组与非ADM组各199例)。匹配分析显示两组皮瓣并发症、血清肿、感染及总体并发症率均无显著差异,多变量分析中ADM亦未与并发症风险增加相关。结论提示必要时可安全使用ADM。

要点

  • 匹配队列中ADM组与非ADM组总体并发症率21.1% vs 26.1%,无显著差异。
  • 皮瓣并发症、血清肿、感染率在两组间均无显著差异。
  • 多变量分析中ADM未增加并发症风险(P=0.511)。

核心结论

  • 匹配队列分析表明ADM使用不增加即刻扩张器-假体乳房再造一期重建的并发症风险,包括皮瓣并发症、血清肿和感染。
  • 结果提示必要时可安全使用ADM。

研究设计与样本

  • 回顾性匹配队列研究,回顾性分析2010年2月至2016年1月前瞻性收集的乳房切除后即刻扩张器-假体乳房再造患者数据。
  • 共纳入574例即刻扩张器-假体乳房再造(533例患者),经倾向性评分匹配后识别398例重建(ADM组与非ADM组各199例)。
  • 匹配后采用Wilcoxon符号秩检验和McNemar检验进行配对比较,并采用多变量广义估计方程分析调整切除与重建外科医生因素。

主要发现

  • 匹配分析中,皮瓣并发症率16.1% vs 16.1%(P > 0.999),血清肿4.0% vs 8.5%(P = 0.065),感染3.0% vs 3.5%(P = 0.781),总体并发症21.1% vs 26.1%(P = 0.251)。
  • 多变量分析考虑切除与重建外科医生因素后,ADM与并发症风险增加无关(P = 0.511)。

临床怎么用

  • 在即刻扩张器-假体乳房再造一期重建中,必要时可安全使用ADM,不增加术后并发症风险。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: Controversy exists regarding complications associated with the use of acellular dermal matrix (ADM). This likely stems from the heterogeneous and unmatched patient characteristics in study groups. The purpose of this study was to analyze complications in a matched cohort to identify whether ADM use increased postoperative complications of the first-stage immediate expander-implant breast reconstructions. METHODS: A retrospective matched-cohort study was performed. We retrospectively reviewed prospectively collected data from patients who underwent immediate expander-implant breast reconstruction after mastectomy between February 2010 and January 2016. Independent variables included clinical characteristics, mastectomy weight, mastectomy type, expander size, initial inflation volume, number of days to drain removal, and adjuvant or neoadjuvant therapies. Different independent variables between the ADM and non-ADM groups were used for propensity score matching. After matching, a pairwise comparison of the 2 cohorts' independent variables was carried out using the Wilcoxon signed rank test and McNemar test. Incidence of complications was evaluated for the 2 matched cohorts. To adjust for ablative and reconstructive surgeons, a multivariable generalized estimating equation analysis was performed. RESULTS: A total of 574 immediate expander-implant breast reconstructions in 533 patients were included in this study. We identified 398 reconstructions (199 for each group; ADM and non-ADM group) of matched cohorts using propensity score matching. Characteristics were similar between the 2 matched cohorts. In the matched analysis, there were no significant differences in the rate of skin flap complications (16.1% vs 16.1%, P > 0.999), seroma (4.0% vs 8.5%, P = 0.065), infection (3.0% vs 3.5%, P = 0.781), and overall complications (21.1% vs 26.1%, P = 0.251). Acellular dermal matrix was not associated with increased risk of complication when ablative and reconstructive surgeon factors were considered in a multivariable analysis (P = 0.511). CONCLUSIONS: A matched cohort analysis demonstrated that ADM usage is not associated with an increased risk of complications, including skin flap complications, seroma, and infection. Our result suggests that ADM can be safely used in immediate expander-implant breast reconstruction when necessary.

来源:Ann Plast Surg,查看原文。版权归原作者所有。

引用

  1. Woo KJ, Park JW, Mun GH, et al. Does the Use of Acellular Dermal Matrix Increase Postoperative Complications of the First-Stage Reconstruction of Immediate Expander-Implant Breast Reconstruction: A Matched Cohort Study. Ann Plast Surg. 2017. PMID: 28509694. doi:10.1097/SAP.0000000000001067

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。